Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Topical Administration of BOS-475 in Healthy Subjects and Patients With Psoriasis
Clinical trial NCT03960450 · COMPLETED
Trial details
- NCT number
- NCT03960450
- Sponsor
- Boston Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-23
- Primary completion
- 2020-01-28
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.